Skip to content
2000
Volume 21, Issue 8
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526520666210104152256
2021-12-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526520666210104152256
Loading

  • Article Type:
    Review Article
Keyword(s): chronic liver diseases; cirrhosis; Coronavirus disease; COVID-19; HCC; pandemic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test